All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Reported results | 2006-003328-12 | A multi-centre, randomized, controlled, single-blinded, phase II study to investigate the safety and efficacy of intravenous infusions of FERINJECT® versus placebo in patients with thrombocytosis seco... | 2010-01-31 | due-trials |
| Reported results | 2006-004608-37 | A randomised double-blind controlled phase III study to compare the efficacy and safety of intravenous ferric carboxymaltose (Ferinject) with placebo in patients with chronic heart failure and iron de... | 2009-07-17 | due-trials |
| Reported results Terminated | 2007-001517-41 | Comparative study of the efficacy and tolerability of iron polymaltose complex film-coated tablets with folic acid (Maltofer® Fol film-coated tablets) compared to a generic iron sulphate product in pr... | 2009-09-11 | due-trials |
| Not reported | 2007-003565-40 | An open-label randomized Phase II study of PA21 compared to sevelamer to evaluate the ability of PA21 to control serum phosphate levels and the tolerability in patients with chronic kidney disease und... | 2007-12-13 | due-trials |
| Reported results | 2008-001503-26 | EFfect of Ferric Carboxymaltose on exercIse CApacity and Cardiac function in patients with iron deficiencY and chronic Heart Failure (EFFICACY-HF) | 2009-10-31 | due-trials |
| Reported results | 2008-002333-75 | A multi-centre, randomised, prospective, open-label study to investigate the efficacy and safety of a standardised correction dosage regimen of intravenous ferric carboxymaltose (FERINJECT®) versus ir... | 2009-12-10 | due-trials |
| Reported results | 2008-003591-22 | A multi-centre, randomised, prospective, single-blinded, controlled study to investigate the efficacy and safety of a standardised maintenance dosage regimen of intravenous ferric carboxymaltose (FERI... | 2010-08-30 | due-trials |
| Reported results | 2008-004748-36 | An open-label, randomized, active controlled multi center phase II dose finding study to evaluate the ability of PA21 to lower serum phosphate levels and the tolerability in patients with chronic kidn... | 2009-10-05 | due-trials |
| Reported results Terminated | 2009-009983-29 | A Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multiple-Dose Study to Evaluate the Effects of RLY5016 in Heart Failure Patients | 2010-01-12 | due-trials |
| Reported results | 2009-015579-28 | An Open-label, Multicentre, Randomised, 3-arm Study to Investigate the Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (Ferinject High- and Low-dosage Regimens) versus Oral Iron f... | 2013-02-12 | due-trials |
| Reported results | 2009-015766-56 | A randomised controlled parallel group open-label study to evaluate the efficacy and safety of intravenous ferric carboxymaltose versus no treatment in anaemic subjects with multiple myeloma and iron-... | 2011-06-01 | due-trials |
| Reported results | 2009-015767-14 | A randomised controlled parallel group open-label study to evaluate the efficacy and safety of intravenous ferric carboxymaltose versus no treatment in anaemic subjects with lymphoid malignancies and ... | 2012-11-09 | due-trials |
| Reported results | 2009-017658-11 | An open-label, multicentre, randomised, 2-arm study to investigate the comparative efficacy and safety of intravenous ferric carboxymaltose versus oral iron for the treatment of iron deficiency anaemi... | 2014-05-16 | due-trials |
| Reported results | 2009-017737-21 | A Multicentre Randomised Placebo-controlled Study to Assess the Efficacy and Safety of a Single Administration of Ferric Carboxymaltose (1,000 mg iron) in Improving Fatigue Symptoms in Iron-deficient ... | 2011-11-08 | due-trials |
| Reported results | 2010-018838-45 | A Multicenter, Open-Label, Single-Arm Study to Evaluate a Titration Regimen for RLY5016 in Heart Failure Patients with Chronic Kidney Disease | 2010-11-05 | due-trials |
| Reported results | 2010-022011-19 | An Open-label, Randomised, Active-controlled, Parallel Group, Multicentre, Phase 3 Study to Investigate the Safety and Efficacy of PA21 Compared with Sevelamer Carbonate Followed by a Randomised Compa... | 2012-04-09 | due-trials |
| Reported results | 2010-022012-40 | An Open-label, Randomised, Active-controlled, Parallel Group, Multicentre Phase 3 Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21 Compared with Sevelamer Carbonate in Dial... | 2012-10-25 | due-trials |
| Reported results | 2011-000165-12 | A Multicenter, Randomized, Open-Label, Dose Ranging Study to Evaluate the Efficacy and Safety of RLY5016 in the Treatment of Hyperkalemia in Patients with Hypertension and Diabetic Nephropathy Receivi... | 2013-06-17 | due-trials |
| Reported results | 2011-000603-40 | Multicentre, prospective, randomised, 2-arm study to assess the impact of ferric carboxymaltose on exercise capacity in chronic heart failure patients with iron deficiency | 2016-05-18 | due-trials |
| Reported results | 2011-001695-19 | A Randomised, Double-blind Controlled Phase 4 Study to Compare the Efficacy and Safety of Intravenous Ferric Carboxymaltose with Placebo in Patients with Chronic Heart Failure and Iron Deficiency | 2014-02-13 | due-trials |
| Reported results | 2012-001956-20 | A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia | 2013-08-06 | due-trials |
| Reported results | 2013-000574-30 | A Randomised, Assessor- and Patient-blind, Multicentre, Placebo-controlled Study to Assess the Efficacy and Safety of a Single Administration of Ferric Carboxymaltose in Improving Outcomes in Iron Def... | 2015-09-01 | due-trials |
| Reported results | 2015-004155-43 | An Open-label, Randomised, Active-controlled, Parallel Group, Multicentre, Phase 3 Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Ad... | 2019-02-21 | due-trials |
| Reported results | 2016-001467-36 | A Randomised, Double-blind Placebo Controlled Trial Comparing the Effect of Intravenous Ferric Carboxymaltose on Hospitalisations and Mortality in Iron Deficient Patients Admitted for Acute Heart Fail... | 2020-07-21 | due-trials |
| Reported results | 2016-002657-38 | A Randomized, Double-Blind, Placebo controlled, Parallel Group Study of Patiromer for the Enablement of Spironolactone Use for Blood Pressure Control in Patients with Resistant Hypertension and Chroni... | 2018-11-27 | due-trials |
| Reported results | 2016-002785-31 | A Phase 2, Open-Label, Multiple Dose Study to Evaluate the Pharmacodynamic Effects, Safety, and Tolerability of Patiromer for Oral Suspension in Children and Adolescents 2 to < 18 Years of Age with Ch... | 2022-05-13 | due-trials |
| Completed, but no date | 2018-002293-44 | A Pragmatic randomized study to evaluate the comparative effectiveness of Akynzeo® and Standard of care (including Emend®) for the prevention of nausea and vomiting (CINV) in cancer patients receiving... | bad-data | |
| Ongoing | 2018-003184-65 | POREIIL - Postoperative replacement of intraoperative iron losses POREIIL - Postoperativer Ersatz von intraoperativen Eisenverlusten | not-yet-due | |
| Listed as ongoing, but also has a completion date and reported results | 2018-005030-38 | A Multicenter, Double-blind, Placebo controlled, Randomized Withdrawal, Parallel Group Study of Patiromer for the Management of Hyperkalemia in Subjects Receiving Renin Angiotensin Aldosterone System ... | 2021-09-02 | bad-data |
| Reported results | 2019-002221-29 | A Phase 2a, Double-blind, Randomised, Placebo-controlled, Parallel Group, Multicentre Study on Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Multiple Doses of VI... | 2021-11-03 | due-trials |
| Reported results | 2019-004696-40 | A phase IV, randomized, double blind cross-over study to evaluate palatability of Patiromer compared to Sodium Polystyrene Sulfonate in healthy subjects | 2020-09-03 | due-trials |
| Completed, report not yet due | 2020-005072-34 | A Phase 2a, double-blind, randomised, placebo controlled, efficacy, and safety study of multiple doses of VIT-2763 in subjects with sickle cell disease (ViSion Serenity) | 2024-03-07 | not-yet-due |
| Reported results Terminated | 2021-001639-23 | A Phase 2b, double-blind, randomised, placebo-controlled, multicentre study to assess the efficacy and safety of VIT-2763 multiple doses in adults with transfusion-dependent ß-thalassaemia Studio d... | 2022-09-29 | due-trials |